CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. | Not long after the state of Louisiana sued ...

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

The U.S. Supreme Court declined to review a 2023 ruling by the 10th U.S. Circuit Court of Appeals striking down provisions of an Oklahoma law regulating pharmacy benefit managers, The Journal Record ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

Lawsuits were filed against CVS and its pharmacy benefit manager, accusing them of unfair practices and illegal lobbying.

Louisiana’s attorney general accuses CVS and Caremark of using patient data to push legislation and inflating drug prices, ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...